Correct option is C
Explanation of the correct answer:
The incorrect statement is Option 3. Here's why:
Option 3: "Mutations reduce ROS production since electron transport is faulty." This statement is incorrect because mutations in the mitochondrial genome generally lead to increased reactive oxygen species (ROS) production, not a reduction. Mitochondria are the main sites of ROS production during oxidative phosphorylation, and when mutations occur in the mitochondrial DNA, particularly in components of the electron transport chain, there is often an increased generation of ROS due to faulty electron transport. These ROS can cause further damage to the cell, contributing to aging and disease.
Information Booster:
ROS Production: ROS are byproducts of the mitochondrial electron transport chain. When mutations in the mitochondrial DNA occur, especially in the genes encoding components of the electron transport chain, these defective proteins can cause incomplete electron transfer, leading to the leakage of electrons and an increased production of ROS. High ROS levels contribute to cellular damage and aging by causing oxidative stress.
Additional Information about Correct Options:
Option 1: "Mutations in mitochondrial genome lead to defects in energy production." This is true. Mutations in mitochondrial DNA can impair mitochondrial function, particularly the ATP production process, leading to energy deficits in the cell.
Option 2: "The mutation rate in mitochondria is much higher than that in the nucleus." This is also true. Mitochondrial DNA is more prone to mutations than nuclear DNA because mitochondria lack the same efficient DNA repair mechanisms as the nucleus and are exposed to higher oxidative stress, which leads to a higher mutation rate.
Option 4: "There is an enhanced rate of apoptosis in cells with mutant mitochondria." This is true. When mitochondria are damaged, they often trigger apoptosis (programmed cell death) as a protective mechanism to prevent the spread of damaged cells, which is especially important in aging tissues.


